Linnea SA ’s Post

Italy's recent decision to ban synthetic foods and restrict the use of "meat" for plant-based products is a step backward in food innovation. Here’s why: Sustainability: Synthetic and plant-based foods offer a way to feed the growing population while reducing environmental impact. Lab-grown meat can cut emissions by 96% and uses 99% less land than livestock farming. Health & Safety: These foods undergo rigorous testing, offering controlled nutritional content and reducing contamination risks compared to traditional meat. Economic Growth: By banning synthetic foods and limiting plant-based labels, Italy is missing out on a billion-dollar industry, job creation, and investment opportunities. Cultural Evolution: Food culture evolves with societal changes. Terms like "vegan meat" help consumers make informed choices without threatening traditional cuisine. Scientific Evidence: Research shows consumers aren’t confused by plant-based labels. Clear labeling is essential for transparency and choice. Conclusion: Instead of bans, Italy should set standards for synthetic and plant-based foods, allowing innovation and tradition to coexist while promoting sustainability. #vegan

The idea that a human being can create foods that support life is interesting. My science model offers a new approach to look at food not from the ideas of protein, carbohydrates, fats etc but from a quantum perspective. How much quantum coherent water does your food contain? How much entanglement has taken place to generate a coherent matrix that is life sustaining? Natural foods have a complexity that is functional for supporting life. Processing foods generates lifeless matter, which enhances shelf life but may be better for making objects than sustaining life.

In recent months, several countries have called for bringing back pharma production (including finished dosages and active pharmaceutical ingredients) to locations within national borders, also known as reshoring. This blog explains what the authorities have in mind, how it specifically relates to APIs, and the role Teva api is playing in this discussion. Read it now!

My Op-Ed in Business Line on 30 April 2024. The analysis shows that India's dependence on china for active pharmaceutical ingredients have increased in recent past. Then, what about the impact of the PLI Scheme that focuses on reducing import dependence? An analysis of some of the products covered by the scheme shows a mixed result. It appears that the scheme is yet to be acclimatised with the dynamics of the API segment which is dominated by small and medium enterprises.

let us follow them in their decision..

I understand why synthetic food is a thing. Eight billion people on the planet and there’s a massive crises surrounding sustainability, and the temptation to synthesise is overpowering. However, I also think we as a species are playing God too much. Sometimes playing God might be the right thing to do, such as bringing back mammoths, in the hopes of stabilising global warming in the arctic and protecting permafrost. But, playing God is also a very bad idea. We as a species are arrogant and naive individuals. We believe we know better. We believe we know everything. The reality is, we don’t. If we did know everything, we wouldn’t be attempting to reverse woolly mammoth extinction to save our planet and ultimately the human race. We wouldn’t have to dig ourselves out of this massive proverbial hole we have dug ourselves and plonked ourselves into. We need to rejuvenate old agricultural practices that have been proven to sustain, nurture, supply, replenish, and stabilise. We need to be planting healthy produce and utilising our food in a fertilising and damage reversing way. We also need to look at ourselves as a species and consider population management, as with other species that know how to sense their resources using something called quorum sensing, where those species respond biologically in an appropriate way to manage resources for the present population density. Species are supposed to reduce their numbers when there isn’t enough resources to continue population rate/growth. We are the only species on this planet that fails to acknowledge lack of resources for current population growth. Why? Because we have had it drilled into us that the goal, the aim, isn’t to sustain our micro environments, we have had it drilled into us that the goal, the aim, is a completely different type of growth. Economic growth in the financial world. And that’s why world leaders will never look to slow down our population rate, because that would damage financial growth. And yet, it’s financial and population growth that will kill the human race. It won’t be Charles Darwin’s survival of the fittest that causes it because that’s organic survival of the fittest. When it’s financial economic growth causing survival of the ‘fittest’ (richest) amongst our race, it isn’t sustainable, it isn’t measured and controlled, it is naive, and it will ultimately lead to the demise of the entire human race.

Have cell-based/synthetic foods been impacting human #health like fast foods or pharmaceutical products have? We’ve done our deep dives into cell-based/synthetic foods scientific studies and their impacts, including potential side effects, immediate to long terms, to consumers. 🆘The current speed of #climatechange acceleration might result in large portions of lands worldwide be under water 🌊 sooner than forecasts. Since humans internal systems have been healthiest with nutritions/foods that’re naturally grown in #nature, we either gotta 🧐adapt and grow new nutritious types of foods in water, or 🧐 thoroughly making cell-based/synthetic foods as safe nutritious alternatives and with minimal side effects as possible. Otherwise, cell-based/synthetic foods would just add into the global extremely heavy burdens of #diseases and their costs the ways fast foods and many pharmaceutical products have. Giang Pham bePrana Wellness

Kudos to Italy! Cell-based and synthetic foods pose tangible risks to human health and the environment. These risks include nutritional, biological, and chemical factors (Wang et al., 2024). Specific health concerns include allergies, antibiotic resistance, carcinogens, and pathogenicity or toxicity (Hewett et al., 2016). Environmental risks encompass changes to ecosystems, competition with native species, and horizontal gene transfer (Hewett et al., 2016). To address these risks, improved detection methods and processing technologies are needed (Wang et al., 2024). Additionally, collaborative efforts between producers, regulators, and consumers are crucial for developing safety standards, increasing awareness, and promoting supportive policies (Waseem & Majeed, 2023). As the industry grows rapidly, with 371 startups globally, there is an urgent need for comprehensive regulatory frameworks and continued research to ensure the safety and acceptance of these novel food products (Waseem & Majeed, 2023).

My Op-Ed in Business Line on 30 April 2024. The analysis shows that India's dependence on china for active pharmaceutical ingredients have increased in recent past. Then, what about the impact of the PLI Scheme that focuses on reducing import dependence? An analysis of some of the products covered by the scheme shows a mixed result. It appears that the scheme is yet to be acclamatised with the dynamics of the API segment which is dominated by small and medium enterprises.

I have recently learned that 25% of carbon emissions from pharmaceutical companies can be attributed to the manufacturing of active pharmaceutical ingredients (APIs), the biologically active part of most drugs. The main reason is that the majority are still chemically synthesised from crude oil and natural gas. But, there is some good news, if the industry can recognise the benefit of investing in different manufacturing techniques and the regulators can support this through a clear and efficient approval process, significant reductions can be made. With pressure coming from pharmaceutical companies who have committed to significant Scope 1, 2, and 3 emissions reductions (with a number of pledges to get to net zero within the next 20 years), will the API industry be able to respond and continue to support the demands of the industry? It is certainly going to be interesting seeing how this unfolds.